Add to ORKGRoutine vaccination with the meningococcal conjugate vaccine MCV4 (Menactra) is indicated for all US adolescents entering high school and for college freshmen living in dormitories (strength of recommendation [SOR]: B, based on observational studies). Routine vaccination of infants and toddlers with conjugate vaccine may be more cost- effective than targeting adolescents, but conjugate meningococcal vaccine for this age group is not yet available in the US (SOR: B, based on cohort studies)
At its June 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended that a...
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menact...
Neisseria meningitidis is a leading cause of bacterial meningitis and septicemia in the United State...
Meningococcal disease, presenting primarily as meningococcemia and meningitis, continues to be a dev...
AbstractNeisseria meningitidis is a common cause of bacterial meningitis and septicemia that can lea...
During its October 2013 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended...
This paper describes meningococcal disease and the vaccines used to treat it. Topics include: Why g...
Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Invasive men...
Meningococcal ACWY vaccine can help protect against meningococcal disease caused by serogroups A, C,...
Meningococcal B disease is associated with a mortality of up to 10% and significant morbidity in sur...
Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routin...
AbstractVaccination programs employing capsular-based meningococcal vaccines have proved successful ...
Serogroup C meningococcal (MenC) disease accounts for one-third of all meningococcal cases and cause...
Meningococcal vaccines help protect against the bacteria that cause meningococcal disease. These inf...
AbstractFacing the availability of the new generation of quadrivalent meningococcal conjugate vaccin...
At its June 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended that a...
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menact...
Neisseria meningitidis is a leading cause of bacterial meningitis and septicemia in the United State...
Meningococcal disease, presenting primarily as meningococcemia and meningitis, continues to be a dev...
AbstractNeisseria meningitidis is a common cause of bacterial meningitis and septicemia that can lea...
During its October 2013 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended...
This paper describes meningococcal disease and the vaccines used to treat it. Topics include: Why g...
Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Invasive men...
Meningococcal ACWY vaccine can help protect against meningococcal disease caused by serogroups A, C,...
Meningococcal B disease is associated with a mortality of up to 10% and significant morbidity in sur...
Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routin...
AbstractVaccination programs employing capsular-based meningococcal vaccines have proved successful ...
Serogroup C meningococcal (MenC) disease accounts for one-third of all meningococcal cases and cause...
Meningococcal vaccines help protect against the bacteria that cause meningococcal disease. These inf...
AbstractFacing the availability of the new generation of quadrivalent meningococcal conjugate vaccin...
At its June 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended that a...
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menact...
Neisseria meningitidis is a leading cause of bacterial meningitis and septicemia in the United State...
